Treatment of Hemorrhagic Fever With Ribavirin
Condition(s):Hemorrhagic FeverLast Updated:July 22, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Hemorrhagic FeverLast Updated:July 22, 2022Not yet recruiting
Condition(s):Follicular Lymphoma; Mantle Cell LymphomaLast Updated:September 27, 2021Terminated
Condition(s):HEAD & NECK CancerLast Updated:October 2, 2023Completed
Condition(s):Hepatitis C; HIVLast Updated:May 1, 2017Completed
Condition(s):Hepatitis C VirusLast Updated:September 16, 2021Completed
Condition(s):Hepatitis C, ChronicLast Updated:August 22, 2016Completed
Condition(s):Chronic Hepatitis CLast Updated:February 26, 2014Completed
Condition(s):Hemorrhagic Fever With Renal SyndromeLast Updated:January 2, 2020Withdrawn
Condition(s):Hepatitis C Infection; HIVLast Updated:June 3, 2019Completed
Condition(s):Human Papillomavirus (HPV)-Related Malignancies; Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related MalignanciesLast Updated:January 5, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.